Proton Pump Inhibitors Reduce the Size and Acidity of the Gastric Acid Pocket (original) (raw)

1. Rohof, WO, Bennink, RJ, and Boeckxstaens, GE (2014). Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach. Clin Gastroenterol Hepatol. 12, Array-1107.
   
2. Fletcher, J, Wirz, A, Young, J, Vallance, R, and McColl, KE (2001). Unbuffered highly acidic gastricjuice exists at the gastroesophageal junction after a meal. Gastroenterology. 121, 775-783.
   
3. Goetze, O, Treier, R, and Fox, M (2009). The effect of gastric secretion on-gastric physiology and emptying in the fasted and fed stateassessed by magnetic resonance imaging. Neurogastroenterol Motil. 21, Array.
   
4. Clarke, AT, Wirz, AA, and Manning, JJ (2008). Severe reflux disease is associated with an enlarged unbuffered proximal gastric acidpocket. Gut. 57, 292-297.
   
5. Grigolon, A, Cant?, P, and Bravi, I (2009). Subcardial 24-h wireless pH monitoring in gastroesophageal reflux disease patients with and without hiatal hernia compared with healthy subjects. Am J Gastroenterol. 104, 2714-2720.
   
6. Beaumont, H, Bennink, RJ, de Jong, J, and Boeckxstaens, GE (2010). The position of the acidpocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut. 59, 441-451.
   
7. Mandel, KG, Daggy, BP, Brodie, DA, and Jacoby, HI (2000). Review article: alginate-raftformulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 14, 669-690.
   
8. Kwiatek, MA, Roman, S, and Fareeduddin, A (2011). An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial ‘acid pocket’ in symptomatic GERD patients. Aliment Pharmacol Ther. 34, 59-66.
   
9. Sweis, R, Kaufman, E, and Anggiansah, A (2013). Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomized, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther. 37, 1093-1102.
   
10. Rohof, WO, Bennink, RJ, Smout, AJ, Thomas, E, and Boeckxstaens, GE (2013). An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux inpatients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 11, 1585-1591.
    
11. De Ruigh, A, Roman, S, Chen, J, Pandolfino, JE, and Kahrilas, PJ (2014). Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study. Aliment Pharmacol Ther. 40, 531-537.